Elite Pharmaceuticals Inc (ELTP)

[Just give me $1.50]

WRONG.

Latest data is about $1.2 billion, down from $1.5 billion.

This much discussed potential CNS ANDA that he speaks of having a $1.5 B market (generic Concerta or something else) is based on September 2019 IQVIA numbers. With a CAGR at 8.5%, we can reasonably expect IQVIA to project this drug - whatever it might be - to be about $1.75 B market today.